5A2-SC8
化学名称
2-[3-[2-[2-[2-[2-[bis[3-[2-(2-methyl-3-octylsulfanylpropanoyl)oxyethoxy]-3-oxopropyl]amino]ethylamino]ethyl-[3-[2-(2-methyl-3-octylsulfanylpropanoyl)oxyethoxy]-3-oxopropyl]amino]ethylamino]ethyl-[3-[2-(2-methyl-3-octylsulfanylpropanoyl)oxyethoxy]-3-oxopropyl]amino]propanoyloxy]ethyl 2-methyl-3-octylsulfanylpropanoate
5A2-SC8•LNP
Structure: 
产品编号
CH51066
CAS
1857341-90-2
分子式
C93H173N5O20S5
分子量
1841.72
规格标准
| Catalog No. | CH51066 |
| CAS No. | 1857341-90-2 |
| Molecular Formula | C93H173N5O20S5 |
| Molecular Weight | 1841.72 |
品类工艺支持
CHEMOS supports custom synthesis and process development for LNP lipid components, with work planned according to target structure, requested scale, and analytical requirements. Ionizable lipid route development : route scouting, impurity review, stereochemistry control, and purification planning. Helper lipid and PEG-lipid preparation : support for phospholipids, sterol-related components, PEG-lipids, and related analogs. Analytical support : HPLC, NMR, MS, Karl Fischer water content, elemental analysis, and residual-solvent testing can be discussed by project. Scale-up support : transfer from laboratory preparation to larger pilot or production batches after route and quality review. Project documentation : batch-specific COA and technical information are provided according to the confirmed specification.
概况
5A2-SC8 (CAS 1857341-90-2, MF C93H173N5O20S5, MW 1841.72) belongs to the ionizable lipid class used in LNP delivery system research for mRNA, siRNA and gene-editing cargos. Programs working with this compound usually examine the head-group / tail combination, related-substance profile, and stereochemistry. Bench-scale to larger-scale production is supported through CHEMOS organic chemistry workflows and dedicated process-development resources.
应用
- 5A2-SC8 (1857341-90-2) supply and analog preparation for research programs
- Ionizable lipid library and head-group / tail analog screening
- Custom analog synthesis with controlled head-group and tail variants
- Analytical method development for ionizable lipid related substances